AN2 Therapeutics, Inc.
ANTXNASDAQHealthcareBiotechnology
Previous close
$5.81
+$0.02 · +0.35%
ANTX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
37
Expensive
Momentum
76
Gaining
Sentiment
52
Mixed
Risk resilience
45
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Eric E. Easom
- Listed since
- Mar 25, 2022
- Employees
- 21
Market position
Day range
Current $5.81
52-week range
Current $5.81
- Open
- $5.87
- Previous close
- $5.79
- Volume
- 225.45K
- 0.79× average
- Average volume
- 285.45K
- Average daily volume
- Market cap
- 209.25M USD
- Beta
- -0.99
- Market reference 1
- 50-day average
- $5.1554
- +12.70% above average
- 200-day average
- $3.1534
- +84.24% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 14.5M USD
- P/E (TTM)
- -5.43×
- P/B (TTM)
- 3.43×
- P/S (TTM)
- 0×
- EV / EBITDA
- -0.41×
- Earnings yield
- -102.11%
- Free cash flow yield
- -86.61%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -66.29%
- Return on assets
- -56.78%
- Return on invested capital
- -71.59%
Financial health
- Debt / equity
- 0×
- Current ratio
- 6.87×
Earnings
- EPS beat rate
- 45%
- 5 beats, 5 misses, 1 met estimate
- Average EPS surprise
- -2.14%
- 11 comparable reports
- Latest EPS result
- -0.18
- Estimate -0.24 · Beat by 25.00%
EPS: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$9.00
54.91% upsideANTX news
ANTX peers
ETFs holding ANTX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI4.56M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM3.44M0.00%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF1.93M0.00%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN1.12M0.01%14.66B USD0.24%$224.81+0.45%
Vanguard Russell 2000 ETFVTWO792.93K0.00%17.4B USD0.06%$121.25+0.74%
iShares Micro-Cap ETFIWC521.22K0.03%1.53B USD0.60%$198.39+1.10%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC226.47K0.02%1.08B USD0.20%$91.32+0.82%
Dimensional - US Small Cap ETFDFAS205.06K0.00%15.92B USD0.26%$83.02+0.73%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 4.56M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 3.44M
- Weight
- 0.00%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 1.93M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 1.12M
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Russell 2000 ETFVTWO- Market value
- 792.93K
- Weight
- 0.00%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
iShares Micro-Cap ETFIWC- Market value
- 521.22K
- Weight
- 0.03%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC- Market value
- 226.47K
- Weight
- 0.02%
- AUM
- 1.08B USD
- Expense ratio
- 0.20%
- Price / 1D
- $91.32+0.82%
Dimensional - US Small Cap ETFDFAS- Market value
- 205.06K
- Weight
- 0.00%
- AUM
- 15.92B USD
- Expense ratio
- 0.26%
- Price / 1D
- $83.02+0.73%
Continue in GoAI
Research ANTXresearch.disclaimer